EUVIMEDEUVIMED entdecken
Crossref

Sensitive and Robust Capillary Electrophoretic Analysis of Host Cell Residual DNA in Biopharmaceutical Samples

Laura N Taylor, Paul F Gillespie iD, Richard R Rustandi, Matthew Schombs, Adam T Sutton iD, Wan Zhou iD

Analytical Chemistry · 2026

DOI: 10.1021/acs.analchem.6c04185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Laura N Taylor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey07065, United States. Hauptthemen laut MEDLINE: DNA, Biological Products. Die Arbeit nennt 34 Literaturangaben. Gefördert von: MSD Sharp and Dohme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Host cell residual DNA (rDNA) is a critical process-related impurity in biopharmaceutical production, involving trace amounts of DNA fragments originating from yeast, bacteria, CHO (Chinese hamster ovary), and other host cells. Monitoring both the size and quantity of rDNA is essential because of potential safety risks, including oncogenicity and immunogenicity, in biological products such as vaccines and other protein therapeutics. Regulatory guidelines from the WHO and U.S. FDA recommend limits of less than 10 ng/dose and below 200 base pairs (bp) for the rDNA content and size in final products. In this work, innovative capillary electrophoresis (CE) technologies that can accurately size rDNA were explored using a single-capillary (BIABooster) CE system and confirmed with a 12-capillary (Femto Pulse) CE system. After optimizing the sample diluent, detection parameters, and hydrodynamic injection volumes, the BIABooster method achieved highly sensitive detection at 200 bp in the linear range of 0.035 ng/mL to 1 ng/mL, with an LOD of 0.035 ng/mL (i.e., 0.0175 ng in 0.5 mL dose, S/N = 3) and an LOQ of 0.065 ng/mL (i.e, 0.0325 ng in 0.5 mL dose, S/N = 10). As a proof of concept, this method was successfully applied to separate rDNA in real biopharmaceutical samples, including yeast-derived in-process intermediate (IPI) samples and CHO-derived final products, showing high sizing accuracy (99.8–104.2%) and robust performance with an intermediate precision of 2.5% RSD from 200 bp to 1000 bp, across preparations, days, analysts, and capillary lots. Compared to conventional methods in rDNA analysis, this method offers advantages including high sensitivity and accuracy, automation, and no need for DNA probe design and amplification steps, resulting in faster method development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNABiological ProductsElectrophoresis, CapillaryAnimalsCHO CellsCricetulusCricetinae

Substanzen

DNABiological Products

Autor:innen und Institutionen

  • Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey07065, United States.
  • C Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, West Virginia26505, United States.

ORCID-Profile: Paul F Gillespie, Adam T Sutton, Wan Zhou

Förderung

  • MSD Sharp and Dohme

Zitieren

APA

Taylor, L. N., Gillespie, P. F., Rustandi, R. R., Schombs, M., Sutton, A. T., & Zhou, W. (2026). Sensitive and Robust Capillary Electrophoretic Analysis of Host Cell Residual DNA in Biopharmaceutical Samples. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c04185

Vancouver

Taylor LN, Gillespie PF, Rustandi RR, Schombs M, Sutton AT, Zhou W. Sensitive and Robust Capillary Electrophoretic Analysis of Host Cell Residual DNA in Biopharmaceutical Samples. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c04185

BibTeX
@article{Taylor2026,
  author = {Taylor, Laura N and Gillespie, Paul F and Rustandi, Richard R and Schombs, Matthew and Sutton, Adam T and Zhou, Wan},
  title = {Sensitive and Robust Capillary Electrophoretic Analysis of Host Cell Residual DNA in Biopharmaceutical Samples},
  journal = {Analytical Chemistry},
  year = {2026},
  doi = {10.1021/acs.analchem.6c04185}
}
Kostenlos starten →